Test
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
H-Asp-Asp-OH, 58471-53-7, C8H12N2O7, Mr 248.19, 1g. Dipeptides as aspartylaspartate and glutamylglutamate can be utilized as growth substrates for the oral bacteria Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
GMP Pacific Blue™ anti-human CD5 [L17F12]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: FC; Size: 100 tests
GMP APC/Fire™ 750 anti-human CD5 [L17F12]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: FC; Size: 100 tests
GMP FITC anti-human CD5 [L17F12]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: FC; Size: 100 tests
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
HBV (HLA Class I Control) Peptide Pool is a lyophilized mixture of 9 peptides from the hepatitis B virus (HBV). The pool consists of defined HLA class I-restricted T cell epitopes and can be used as an antigen-specific positive control to stimulate T cells.
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
This item has a minimum order quantity of 3 per supplier requirements
Purity: , M.W. > 12,000 cut off by dialysis, NCA polymerized product, Storage Temperature: -20C
Al @ 10 µg/mL, Mg @ 20 µg/mL Ca @ 32 µg/mL Cu, Fe, Pb, Zn @ 50 µg/mL B @ 1000 µg/mL, P @2000 µg/mL K @ 5000 µg/mL Na @10,000 µg/mL Matrix: 3% HNO3 (v/v) Volume: 500 mL
WuXi TIDES Fmoc-D-Phe(3,4-DiCl)-OH, 177966-58-4 | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid | ClC=1C=CC(=CC1Cl)C[C@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O | M.F. C24H19Cl2NO4, M.W. 456.32
WuXi TIDES Fmoc-L-Phe(3,5-DiCl)-OH, 1260605-95-5 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dichlorophenyl)propanoic acid | O=C(N[C@@H](CC1=CC(Cl)=CC(Cl)=C1)C(=O)O)OCC2C3=CC=CC=C3C4=C2C=CC=C4 | M.F. C24H19Cl2NO4, M.W. 456.32
(D-Arg1,D-Trp7·9,Leu11)-Substance P, H-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2, 91224-37-2, C75H108N20O13, Mr 1497.81, 1mg. Spantide I, [DArg1, DTrp7,9, Leu11] Substance P. Spantide I, a high potency substance P antagonist with a weak spasmogenic and a poor histamine releasing effect.